Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health (Subscription required) Adrienne Rivlin Read more
Article Life Sciences & Pharma Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors July 2, 2024
Executive Insights Life Sciences & Pharma First vs. Best in Class — Simplifying the Equation for Biopharma June 27, 2024
Published Articles Marketing & Sales How Can Businesses Survive the ‘Cookie Apocalypse’? April 25, 2024
Special Report Biotech and Pharmaceuticals Improving the Understanding Acceptance and Use of Oncology–Relevant Endpoints October 31, 2023
Podcast Life Sciences & Pharma Access, Efficacy and Collaboration: Unlocking the Potential of Gene Therapies September 13, 2023